Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients
1 other identifier
observational
20
1 country
1
Brief Summary
This is an observational study examining serum markers in patients who are undergoing either a cadaveric liver transplant or a living related liver transplant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 12, 2008
CompletedFirst Posted
Study publicly available on registry
June 17, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2010
CompletedFebruary 28, 2018
February 1, 2018
1.9 years
June 12, 2008
February 27, 2018
Conditions
Keywords
Study Arms (2)
1
Live Donor
2
Cadaveric Donor
Eligibility Criteria
Subjects will be recruited from those on the list awaiting liver transplantation at Vanderbilt University Medical Center (VUMC). They will be recruited by the investigators prior to the time of their transplantation surgery
You may qualify if:
- American Society of Anesthesiologists (ASA) Class I-V.
- Patient is undergoing elective Liver Transplant Surgery.
- Patient is an adult, 18 years old or older.
You may not qualify if:
- Patients \< 18 Years of Age
- Patients who are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
Related Links
Biospecimen
serum of patients who are undergoing liver transplantation surgery
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey M Waldman, M.D.
Vanderbilt University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2008
First Posted
June 17, 2008
Study Start
March 1, 2008
Primary Completion
February 2, 2010
Study Completion
February 2, 2010
Last Updated
February 28, 2018
Record last verified: 2018-02